Source:http://linkedlifedata.com/resource/pubmed/id/12388259
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2002-12-17
|
pubmed:abstractText |
Angiogenesis is one of the most recent physiological functions attributed to products of cytochrome P-450 (CYP450) enymes. To test this at a molecular level in human cells, we used a cloned cDNA for the human endothelial enzyme CYP450 2C9 (CYP2C9) to study growth as well as differentiation of human microvascular endothelial cells from the lung (HMVEC-L). Using adenoviral vectors overexpressing mRNA for CYP2C9, we show that the presence of CYP2C9 doubles thymidine incorporation and stimulates proliferation of primary cultures of endothelial cells compared with Ad5-GFP (control) in 24 h. In addition, there is a significant increase of tube formation in Matrigel after infection of HMVEC-L with Ad5-2C9 than with Ad5-GFP. More interestingly, Ad5-2C9 expressing the antisense product of CYP2C9 (2C9AS) inhibited tube formation compared with both Ad5-GFP as well as the Ad5-2C9 constructs. Finally, we tested the most abundant arachidonic acid metabolite of CYP2C9, 14,15-epoxyeicosatrienoic acid, which induced angiogenesis in vivo when embedded in Matrigel plugs and implanted in adult rats. These data support an important role for CYP2C9 in promoting angiogenesis.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/14,15-epoxy-5,8,11-eicosatrienoic...,
http://linkedlifedata.com/resource/pubmed/chemical/8,11,14-Eicosatrienoic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Aryl Hydrocarbon Hydroxylases,
http://linkedlifedata.com/resource/pubmed/chemical/CYP2C9 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0363-6135
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
284
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
H215-24
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12388259-8,11,14-Eicosatrienoic Acid,
pubmed-meshheading:12388259-Adenoviridae,
pubmed-meshheading:12388259-Animals,
pubmed-meshheading:12388259-Aryl Hydrocarbon Hydroxylases,
pubmed-meshheading:12388259-Cells, Cultured,
pubmed-meshheading:12388259-DNA,
pubmed-meshheading:12388259-Endothelium, Vascular,
pubmed-meshheading:12388259-Gene Transfer Techniques,
pubmed-meshheading:12388259-Genetic Vectors,
pubmed-meshheading:12388259-Humans,
pubmed-meshheading:12388259-Microcirculation,
pubmed-meshheading:12388259-Neovascularization, Physiologic,
pubmed-meshheading:12388259-Pulmonary Circulation,
pubmed-meshheading:12388259-Rats,
pubmed-meshheading:12388259-Rats, Sprague-Dawley,
pubmed-meshheading:12388259-Vasodilator Agents
|
pubmed:year |
2003
|
pubmed:articleTitle |
Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells.
|
pubmed:affiliation |
Division of Pulmonary and Critical Care, Department of Medicine, Cardiovascular Center, Medical College of Wisconsin, Milwaukee 53226, USA. medhoram@mcw.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|